Encompass Health Reports Strong Q4 & FY25 Results, Issues Positive 2026 Guidance

summarizeSummary

Encompass Health Corp announced strong Q4 and full-year 2025 financial results, with significant growth in revenue and earnings, and provided positive guidance for 2026.

check_boxKey Events

• Strong Q4 2025 Financial Performance

  Net operating revenue increased by 9.9% to $1,544.6 million, Adjusted EBITDA grew 15.9% to $335.6 million, and Adjusted EPS rose 24.8% to $1.46 compared to Q4 2024.

• Solid Full Year 2025 Results

  For the full year, net operating revenue increased 10.5% to $5,935.2 million, Adjusted EBITDA grew 14.9% to $1,267.9 million, and Adjusted EPS increased 23.0% to $5.45.

• Positive 2026 Guidance Issued

  The company projects 2026 net operating revenue between $6,365 million and $6,465 million, Adjusted EBITDA between $1,340 million and $1,380 million, and Adjusted EPS between $5.81 and $6.10.

• Significant Capacity Expansion

  In 2025, Encompass Health opened 8 new hospitals, adding 390 beds, and expanded existing hospitals by 127 beds, demonstrating continued growth in its inpatient rehabilitation capacity.

auto_awesomeAnalysis

Encompass Health Corp delivered robust financial results for both the fourth quarter and full year 2025, exceeding prior-year performance across key metrics. The company reported double-digit growth in net operating revenue, Adjusted EBITDA, and Adjusted EPS, driven by strong same-store discharge growth and significant capacity expansion. The positive momentum is expected to continue into 2026, as indicated by the favorable guidance provided. This strong operational execution and optimistic outlook reinforce the company's growth trajectory and solidifies its market position, making this a very important update for investors.